Tag Archives: Sanofi-Aventis

Has anyone the time, interest or funding for these stories?

June 17, 2009 – 10:57 am

In case there are any researchers or journalists out there with too much time on their hands, here are two ideas for stories or research projects.
• What is the role of the media in Mr Ward’s death?
The 4 Corners report on the death of Mr Ward, an Aboriginal man who was incarcerated in the most [...]

By Croakey | Posted in Crikey register of influence, Health inequalities, Indigenous health, Media-related issues, adverse events, conflicts of interest | Also tagged , , , , , | Comments (4)

The Baker drug deal found in breach

May 21, 2009 – 8:29 am

The controversial sponsorship deal between Sanofi-Aventis and the Baker IDI Heart and Diabetes Institute has been found to be in breach of the Medicines Australia code of conduct.
Under the deal, for every Plavix script dispensed through retail pharmacy in 2009, Sanofi-Aventis agreed to donate 25 cents to support the Baker’s medical research and preventative health [...]

By Croakey | Posted in Media-related issues, health & medical marketing | Also tagged , , | Comments (0)

Some more thoughts on the Baker/Sanofi deal

May 6, 2009 – 12:19 pm

A pharmacy researcher who wishes to remain anonymous has sent in this comment regarding the funding deal between the Baker and Sanofi Aventis (for more background info, see here, and here and here):
“Agreements between not for profit research institutes and the pharmaceutical industry can be fraught with conflict, even if an iron clad contract is [...]

By Croakey | Posted in Crikey register of influence, conflicts of interest, health & medical marketing, health and medical research, health ethics, pharmacy, quality and safety of health care | Also tagged , | Comments (0)

The Baker boss responds to the alarm bells

April 29, 2009 – 6:00 pm

Garry Jennings. director of the Baker IDI Heart and Diabetes Institute, has sent in the following response to concerns raised at Croakey and elsewhere, with a link to a question and answer document on the Institute’s website:
“We thank everyone for their comments. This is an innovative donation arrangement so we are not surprised at the [...]

By Croakey | Posted in Crikey register of influence, Media-related issues, conflicts of interest, health & medical marketing, health ethics | Also tagged , , , | Comments (2)

Some responses to the deal between Sanofi-Aventis and the Baker

April 29, 2009 – 10:57 am

Dr Ken Harvey, Adjunct Senior Research Fellow, School of Public Health, La Trobe University, has written a long comment on my post below, and it is well worth a read. He also advises that he is putting in a complaint to Medicines Australia about the Sanofi-Aventis campaign.
Meanwhile, here are some other comments on the deal:
Dr [...]

By Croakey | Posted in Crikey register of influence, Media-related issues, conflicts of interest, health & medical marketing, health ethics | Also tagged , , , | Comments (0)

Who’s the loser with this clever drug company campaign?

April 28, 2009 – 6:30 pm

You’ve got to hand it to Sanofi-Aventis.
At the same time as the Vioxx case before the Federal Court is producing an alarming string of stories about the hazards of overly close ties between doctors and pharma (as an example, see this story in the Oz and this one in The Age), Sanofi-Aventis has enticed a [...]

By Croakey | Posted in Crikey register of influence, Media-related issues, conflicts of interest, health & medical marketing, health ethics | Also tagged , | Comments (2)

The blood clot controversy thickens

April 20, 2009 – 12:21 pm

Last April, journalist Ray Moynihan wrote this Crikey article revealing that public hospital “guidelines”, recommending widespread use of a group of drugs to stop serious blood clots, had been funded by Sanofi-Aventis, the company that makes one of these drugs.
Moynihan subsequently also reported that an international PR firm Fleishman-Hillard, was involved in a high-profile campaign, [...]

By Croakey | Posted in Hospitals, Journal articles, Media-related issues, adverse events, conflicts of interest, evidence-based issues, health & medical marketing, health ethics, quality and safety of health care | Also tagged , , , | Comments (0)